Informed Consent Clause Samples

Informed Consent. Both of us have reviewed this Agreement with independent legal counsel. We understand the content, legal effect, and consequences of this Agreement, and we are entering into this Agreement voluntarily, free from duress, fraud, undue influence, or coercion of any kind.

Informed Consent. Informed Consent requires that: the Provider has obtained informed consent from the Donor(s) to provide Materials to the Recipient to undertake the Project as contemplated. In the event of Secondary Use of the Materials, the Donor(s) have consented thereto insofar as the Secondary Uses have been approved by the HREC. the Donor(s) have been informed that, where reasonably possible, the Provider will inform them of developments or progress made by the Recipient in the Project and which is relevant to the Donor(s) Informed Consent. the Donor(s) have been informed and have accepted that on termination of this agreement, the Material will be returned to the Provider or destroyed, or any other arrangements made, as determined by the Provider under clause 8. the Donor(s) are aware that all Materials and associated data are de-identified. Disclosure to Donor(s) has been made in the event that Materials will be released into the public domain. should the Recipient wish to conduct studies or use the Material for any other purpose than that approved by the HREC, the Provider must be notified in writing and HREC approval must first be obtained.

Informed Consent. 1.6.1 Institution/Principal Investigator undertakes to use the patient information sheet as approved by the Ethics Committee and to obtain written informed consent from each Study subject prior to inclusion or initiation of any Study specific procedures for screening according to the Protocol.

Informed Consent. The Principal Investigator shall obtain the written informed consent of each Subject prior to any screening or participation in the Study using the Informed Consent Materials (as defined in Section 11.3) and in accordance with Applicable Laws. Institution shall cause each Subject to complete an informed consent form that has been reviewed and approved in advance by SPONSOR and by an institutional review board approved by the Institution that complies with the requirements of 21 C.F.R. Part 56 (“IRB”). The Informed Consent Materials shall not be modified or amended without prior written approval of the SPONSOR and IRB.

Informed Consent. The Employer must obtain the Performer’s Informed Consent (or, if the Performer is deceased, the Informed Consent of the Performer’s estate or authorized representative, as required by applicable law) and negotiate compensation prior to the use of a Performer’s Digital Replica, the Employer shall exercise its rights to use a Digital Replica under this section consistent with its obligations under Article I, Section 19, “Non-Discrimination Policy”. In addition to the information required for Informed Consent, the Employer shall disclose whether the Digital Replica will be used in connection with procedurally generated dialogue. Performer’s Informed Consent for the use of the Performer’s Digital Replica other than in the Interactive Program for which it was originally created must be obtained prior to the use of the Digital Replica, but may not be obtained at the time of initial employment. The minimum for bargaining shall be the compensation set forth in subsection b. below. Any Informed Consent granted under this provision shall be deemed suspended for the duration of any strike conducted in compliance with the Interactive Media Agreement. No consent is required for Processing Practices.

Informed Consent. Principal Investigator will obtain a written informed consent for each Study Subject and will maintain a signed original of that consent in that Study Subject’s record. CRO and/or Pfizer will provide a template informed consent document for the Study which has been approved by the IEC and SUKL. Institution and Principal 7.1 Informovaný souhlas. Hlavní zkoušející získá informovaný souhlas od každého subjektu studie a uloží podepsaný stejnopis tohoto souhlasu v záznamech příslušného Subjektu studie. CRO nebo společnost Pfizer poskytne předlohu dokumentu informovaného souhlasu pro studii, která byla schválena EK a SÚKL. Instituce a Hlavní zkoušející nesmí Investigator must not make any changes to this document with the prior written approval of the CRO or Pfizer (including any revisions made during the course of the Study) before the revised informed consent document is used for the Study. The Institution and Principal Investigator must not recruit potential subjects to participate in the Study, commence the research covered under this Agreement, or administer the Investigational Drug (as defined below) to the Study Subjects unless and until a valid informed consent has been obtained from each Study Subject. provádět žádné změny tohoto dokumentu, aniž by obdrželi předchozí písemný souhlas CRO nebo společnosti Pfizer dříve, než upravený dokument informovaného souhlasu použijí pro Studii (včetně jakýchkoli úprav provedených během Studie). Instituce a Hlavní zkoušející nesmí provádět nábor potenciálních Subjektů pro účast ve Studii, zahájit výzkum, na který se vztahuje tato Smlouva, nebo podávat hodnocené léčivo (tak, jak je definováno níže) Subjektům studie, dokud nebyl získán platný informovaný souhlas od každého Subjektu studie.

Informed Consent. Pharmacy must obtain written informed consent from each individual (or if the individual is incapable of consenting, the person legally responsible for the individual) prior to administering a vaccine.8 Pharmacy must ensure that each individual is informed of potential side effects and adverse reactions orally and in writing prior to administering a vaccine.9 Each individual must be provided with information on the importance of having a primary care provider, in a form or format developed by the Commissioner of Health.10

Informed Consent. 5 Pharmacy must obtain written informed consent from the individual prior to administering the vaccine. Consent to the immunization of a child must be in writing and signed by an authorized person. The written consent must include: the name of the child, the name of one or both parents, if known, the name of any managing conservator or guardian of the child, the name of the person giving consent and the person’s relationship to the child, a statement of the nature of the medical treatment to be given, and the date the treatment is to begin.

Informed Consent. 10.1 The Provider must obtain an informed consent from the Donor(s) to provide Materials to the Recipient to undertake the Project as contemplated. 10.2 The Provider must furnish the completed consent form from the donors together with the project protocol to the HREC for approval. 10.3 The Provider must submit the informed consent form for Secondary Uses of the Material to the HREC should the need arise for Secondary Use. 10.4 The Provider must inform the donors of developments or progress made by the Recipient in the Project and which is relevant to the Donor(s) Informed Consent.